Transcatheter aortic valve replacement golden years are over, says GlobalData
Following Edwards Lifesciences CEO statement on the chilly outlook for transcatheter aortic valve replacement (TAVR); James Spencer, Senior Data Scientist at GlobalData Healthcare, offers his view: “For...
02 November, 2022